Literature DB >> 21673211

Managing hiccups.

Cornelius J Woelk1.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21673211      PMCID: PMC3114667     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Intravenous lidocaine in the treatment of hiccup.

Authors:  S P Cohen; E Lubin; M Stojanovic
Journal:  South Med J       Date:  2001-11       Impact factor: 0.954

2.  Nifedipine for intractable hiccups.

Authors:  D C Lipps; B Jabbari; M H Mitchell; J D Daigh
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

3.  Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience.

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Paolo Aloisi; Brigida Galletti; Corrado Ficorella
Journal:  Clin Neuropharmacol       Date:  2010-07       Impact factor: 1.592

4.  Baclofen therapy for chronic hiccup.

Authors:  C Guelaud; T Similowski; J L Bizec; J Cabane; W A Whitelaw; J P Derenne
Journal:  Eur Respir J       Date:  1995-02       Impact factor: 16.671

Review 5.  Management of hiccups in the palliative care population.

Authors:  Howard S Smith; Atichat Busracamwongs
Journal:  Am J Hosp Palliat Care       Date:  2003 Mar-Apr       Impact factor: 2.500

Review 6.  Diagnosis and management of hiccups in the patient with advanced cancer.

Authors:  Mark A Marinella
Journal:  J Support Oncol       Date:  2009 Jul-Aug

7.  Successful treatment of intractable hiccup with methylphenidate in a lung cancer patient.

Authors:  R Maréchal; T Berghmans; P Sculier
Journal:  Support Care Cancer       Date:  2002-12-07       Impact factor: 3.603

8.  Treatment of intractable hiccup with baclofen: results of a double-blind randomized, controlled, cross-over study.

Authors:  F C Ramírez; D Y Graham
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

  8 in total
  8 in total

1.  Prevalence and associated factors of orphan symptoms in advanced cancer patients: a multicenter observational study.

Authors:  Kaoru Nishijima; Yoshiyuki Kizawa; Toshihiro Yamauchi; Takuya Odagiri; Tetsuya Ito; Keisuke Kaneishi; Keiji Shimizu; Tatsuya Morita; Masanori Mori
Journal:  Support Care Cancer       Date:  2021-03-16       Impact factor: 3.603

2.  Orphan symptoms in advanced cancer patients followed at home.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Alessandro Valle; Flavio Fusco; Federica Aielli; Claudio Adile; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-10-13       Impact factor: 3.603

3.  Persistent Hiccups as an Atypical Presentation of SARS-CoV-2 Infection: A Systematic Review of Case Reports.

Authors:  Panagiotis Giannos; Konstantinos Katsikas Triantafyllidis; Georgios Geropoulos; Konstantinos S Kechagias
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

4.  Intractable Hiccups in an Elderly Diabetic: An Unusual Presentation of Ascaris lumbricoides.

Authors:  Ramesh Aggarwal; Shridhar Dwivedi; Anupam Dey; Shamim Ullah Khan; Meenakshi Aggarwal
Journal:  J Glob Infect Dis       Date:  2013-04

5.  COVID-19 presenting as persistent hiccups: a case report.

Authors:  Diogo Ribeiro de Sene; Diego Moreno Watashi; Isabella de Oliveira Bilitardo; Carlos Eduardo Campos Moreno; Mariella Freire de Freitas Moreno
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-08-06       Impact factor: 1.846

6.  Persistent Hiccups: An Unusual Presentation of Aspiration Pneumonia in the Elderly.

Authors:  Lance De Barry; Narika Singh; Triston De Barry
Journal:  Cureus       Date:  2021-11-12

7.  Comparison the Effects of Ephedrine and Lidocaine in Treatment of Intraoperative Hiccups in Gynecologic Surgery under Sedation.

Authors:  Azadeh Bahadoori; Amir Shafa; Taha Ayoub
Journal:  Adv Biomed Res       Date:  2018-11-27

8.  Acupuncture for hiccups: A systematic review protocol of high-quality randomized trials.

Authors:  Xiao-Bing Li; Dong-Jie Wu; Min-Chun Yang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.